Funding for this research was provided by:
Foundation for the National Institutes of Health (2T32GM068412-11A1)
Received: 5 February 2021
Accepted: 19 March 2021
First Online: 7 April 2021
: The patient was enrolled as part of an Institutional Review Board (IRB) approved study (IRB18-00662) at The Steve and Cindy Rasmussen Institute for Genomic Medicine (IGM) at Nationwide Children’s Hospital (NCH). Informed consent was provided by the patient’s parents for comprehensive genomic analysis and publication.
: V.M. is a Key Opinion Leader at New England Biolabs. The remaining authors declare that they have no competing interests.